Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

GENE - CHEMICAL INTERACTIONS REPORT

RGD ID: 1307993
Species: Rattus norvegicus
RGD Object: Gene
Symbol: Bcr
Name: BCR activator of RhoGEF and GTPase
Acc ID: CHEBI:45716
Term: vorinostat
Definition: A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).
Chemical ID: MESH:C111237
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction is comprised of a complex set of reactions and/or regulatory events, possibly involving additional chemicals and/or gene products.
Object SymbolQualifierEvidenceWithReferenceSourceNotesOriginal Reference(s)
Bcrdecreases expressionISOBCR (Homo sapiens)6480464CTDvorinostat results in decreased expression of BCR mRNA mutant form; vorinostat results in decreased expression of BCR protein mutant formPMID:12446442
Bcrmultiple interactionsISOBCR (Homo sapiens)6480464CTD[Dasatinib co-treated with Vorinostat] results in decreased expression of BCR protein mutant form; [Dasatinib co-treated with Vorinostat] results in decreased phosphorylation of BCR protein mutant form; [tozasertib co-treated with Vorinostat] results in decreased activity of BCR protein mutant form; [Vorinostat co-treated with Imatinib Mesylate] results in decreased expression of BCR protein mutant form; [Vorinostat co-treated with Imatinib Mesylate] results in decreased phosphorylation of BCR protein mutant formPMID:12446442 PMID:17020995 PMID:18829489
Go Back to source page   Continue to Ontology report